In accordance with our data, Schaaf et al. observed that modulation of Spry1 levels had no influence on proliferation of rhabdomyosarcoma if the Ras genes were wildtype, and only if the cells harbor an oncogenic Ras version Spry1 functions as a tumor promoter [31]. This evidence concerns the gene SPRY1 and neoplasm.